Back
AbbVie, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
46
ABBV
AbbVie, Inc.
Last Price:
$226.83
Seasonality Move:
3.6%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAbbVie, Inc. Stock Forecast
-
Over the next 52 weeks, AbbVie, Inc. has on average historically risen by 14.2% based on the past 12 years of stock performance.
-
AbbVie, Inc. has risen higher in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is AbbVie, Inc. Stock Undervalued?The current AbbVie, Inc. [ABBV] share price is $222.82. The Score for ABBV is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will AbbVie, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, AbbVie, Inc. has on average historically risen by 14.2% based on the past 12 years of stock performance.
AbbVie, Inc. Stock Rating
Sell
46
AbbVie, Inc. (ABBV)
is a Sell
Is AbbVie, Inc. overpriced?
-
AbbVie, Inc. has risen higher in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
AbbVie, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
abbvie.com
52-Week Data
52-Week High:
244.81
52-Week Low:
164.39
Prediction Charts
Market Cap:
393.8B
Price in USD:
222.82
Volume:
4.8M
Beta:
0.74
Technical Analysis
SMA50:
226.75
SMA100:
219.82
SMA200:
205.40
52-Wk Change:
28.78%
Stock Predictions
-
Is AbbVie, Inc. stock public?Yes, AbbVie, Inc. is a publicly traded company.
-
What is the AbbVie, Inc. stock quote today?The AbbVie, Inc. stock price is 222.82 USD today.
-
How to buy AbbVie, Inc. stock online?You can buy AbbVie, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-1 | 227.19 | 225.11 | 229.49 | 223.98 |
| Dec-2 | 224.82 | 224.37 | 226.63 | 223.11 |
| Dec-3 | 224.84 | 230.24 | 230.79 | 224.52 |
| Dec-4 | 230.11 | 228.71 | 230.94 | 227.59 |
| Dec-5 | 228.93 | 226.08 | 229.25 | 225.05 |
| Dec-8 | 226.08 | 223.12 | 226.12 | 222.39 |
| Dec-9 | 223.89 | 222.99 | 224.82 | 220.23 |
| Dec-10 | 225.00 | 225.18 | 225.98 | 221.00 |
| Dec-11 | 225.54 | 223.98 | 225.96 | 222.24 |
| Dec-12 | 223.69 | 223.32 | 223.82 | 221.10 |
| Dec-15 | 224.24 | 227.45 | 228.30 | 223.56 |
| Dec-16 | 226.41 | 223.67 | 226.84 | 221.91 |
| Dec-17 | 223.94 | 224.31 | 226.41 | 222.86 |
| Dec-18 | 224.00 | 222.82 | 226.26 | 222.79 |
AbbVie, Inc. Earnings
AbbVie, Inc. Earnings Report: Per Share AbbVie, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
AbbVie, Inc. Forecast Revenue Growth
AbbVie, Inc. Stock Analysis: Historical quarterly revenues per share for AbbVie, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.61 per share.
* AbbVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.